A Special Case of Bilateral Ovarian Metastases in a Woman with Papillary Carcinoma of the Thyroid

Abstract

Papillary thyroid carcinoma is a slow growing tumor with low metastatic potential. The most frequent sites of distant metastases are lung and bone; less frequent sites are brain, liver, kidney, and skin. Ovarian metastases from papillary thyroid carcinoma are exceptional. We describe a case of bilateral ovarian metastases from a papillary thyroid carcinoma associated with autoimmune thyroiditis in a 38-year-old woman who underwent thyroidectomy and cervical lymph-node dissection 7 years before, followed by 948 mCi of 131I. A primary ovarian cancer could be excluded by the typical pathological aspects of a papillary thyroid carcinoma in a context of an aggressive form of thyroid cancer. On the other hand, the clinical history and the absence of normal thyroid epithelium and teratomatous components could exclude a papillary thyroid carcinoma arising in struma ovarii. This is a singular case of papillary thyroid carcinoma metastasizing to the ovary, combined with an autoimmune thyroiditis.

Key words

Thyroid carcinoma - ovarian metastases - immunohistochemistry - thyroglobulin - TTF-1 - autoimmune thyroiditis

References

• 1 Shi Y, Ye D, Lu W, Zhao C, Xu J, Chen L. Histological classification in 10288 cases of ovarian malignant tumors in China.  Zhounghua Fu Chan Ke Za Zhi. 2002;  37 97-100
• 2 Yada-Hashimoto N, Yamamoto T, Kamiura S, Seino H, Ohira H, Sawai K, Kimura T, Saji F. Metastatic ovarian tumors: a review of 64 cases.  Gynecol Oncol. 2003;  89 314-317
• 3 Woodruff JD, Murthy YS, Bhaskar F, Tseng SS. Metastatic ovarian tumors.  Am J Obstet Gynecol. 1970;  107 202-209
• 4 Young R, Jackson A, Wells M. Ovarian metastasis from thyroid carcinoma 12 years after partial thyroidectomy mimicking struma ovarii: report of a case.  Int J Gynecol Pathol. 1994;  13 181-185
• 5 Logani S, Baloch ZW, Snyder PJ, Weinstein R, Livolsi VA. Cystic ovarian metastasis from papillary tyroid carcinoma: a case report.  Thyroid. 2001;  11 1073-1075
• 6 Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, Mac Iver B, Sherman SI, Tuttle RM. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer.  Thyroid. 2006;  16 1-33
• 7 Silverberg SG, Hutter RV, Foote Jr . Fatal carcinoma of the thyroid: histology, metastases, and causes of death.  Cancer. 1970;  25 798-802
• 8 Tollefsen HR, Decosse JJ, Hutter RV. Papillary carcinoma of the thyroid. A clinical and pathological study of 70 fatal cases.  Cancer. 1964;  17 1035-1044
• 9 Rosai and Ackerman's Surgical Pathology. Ninth Edition. 2004 Volume 2: 1649-173 Mosby
• 10 Garcia A, Castellvi J, Lopez M, Gil A, De La Torre J, Ramon Y, Cajal S. Malignant struma ovarii mimic clear cell carcinoma.  Arch Gynecol Obstet. 2004; 
• 11 Webb MJ, Decker DG, Mussey E. Cancer metastatic to the ovary: factors influencing survival.  Obstet Gynecol. 1975;  45 391-396
• 12 Loh KC, Greenspan FS, Dong F, Miller TR, Yeo PPB. Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma.  J Clin Endocrinol Metab. 1999;  84 458-463
• 13 Leboulleux S, Rubino C, Baudin E, Caillou B, Hartl D, Bidart JM, Travagli JP, Schlumberger M. Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis.  J Clin Endocrinol Metab. 2005;  90 5723-5729

Correspondence